Updates in the Surgical Management of Benign and High-Risk Breast Lesions.

Benign breast disease (BBD) is a heterogenous group of lesions often classified as nonproliferative or proliferative, with the latter group further categorized based on the presence of atypia. Although nonproliferative lesions are more common, the risk of breast cancer is elevated in women with proliferative lesions. Historically, the majority of proliferative lesions were excised due to concern for future and/or concomitant breast cancer at the site of the index lesion. However, contemporary data suggest that the risk of cancer associated with various proliferative lesions may be lower than previously thought, and management of BBD has become more nuanced. In this review, we will focus on recent updates in the management of a select group of benign and high-risk lesions.
Competing Interests: Disclosure Chelsea Marin: none. Jessica C. Gooch: none. Anna Weiss: Advisory Board member for Myriad Genetics, Inc. and Merck & Co., Inc.
(Copyright © 2023 Elsevier Inc. All rights reserved.)